Table 2.
Clinical Characteristics | SS | Controls | Test | p Value |
---|---|---|---|---|
Thyroid disease | 22 (30,6%) | 10 (13,9%) | χ2= 5,786 | 0.016 |
Arthromyalgia / polyarticular arthritis | 14 (19,4%) | 3 (4,2%) | Χ2 = 8,070 | 0.004 |
Esophageal disease | 10 (13,9%) | 1 (1,4%) | Χ2 = 7,973 | 0.005 |
Gastritis | 14 (19,4%) | 0 | Χ2 = 15,507 | < 0.001 |
Interstitial lung disease | 6 (8,3%) | 0 | Fisher exact test | 0.014 |
Kidney disease | 7 (9,7%) | 1 (1,4%) | Fisher exact test | 0.031 |
Liver disease | 7 (9,7%) | 0 | Fisher exact test | 0.006 |
Neuropathy | 9 (12,5%) | 1 (1,4%) | Χ2 = 6,878 | 0.009 |
Vasculitis | 6 (8,3%) | 0 | Fisher exact test | 0.014 |
Raynaud disease | 25 (34,7%) | 0 | Χ2 = 30,252 | < 0.001 |
Lymphoproliferative disorders | 2 (2,8%) | 0 | Fisher exact test | 0.248 |
Blood disorders | 9 (12,5%) | 1 (1,4%) | Χ2 = 6,878 | 0.009 |
Osteoporosis | 22 (30,6%) | 1 (1,4%) | Χ2 = 22,818 | < 0.001 |
Hypovitaminosis | 27 (37,5%) | 1 (1,4%) | Χ2 = 29,970 | < 0.001 |
Hypertension | 24 (33,3%) | 19 (26,4%) | Χ2 = 0,829 | 0.362 |
Diabetes mellitus | 5 (6,9%) | 4 (5,6%) | Fisher exact test | 00.05 |
Cardiopathy | 14 (19,4%) | 5 (6,9%) | Χ2 4,912 | 0.027 |
Dyslipidemia | 10 (13,9%) | 3 (4,2%) | Χ2 4,143 | 0.042 |